Metastatic prostate cancer with elevated serum levels of CEA and CA19-9

Guang Dar Juang; Yi-Sheng Huang; Yuan Hung Wang

doi:10.1016/j.urols.2013.05.005

Metastatic prostate cancer with elevated serum levels of CEA and CA19-9

Guang Dar Juang, Yi-Sheng Huang, Yuan Hung Wang

Research output: Contribution to journal › Article › peer-review

6 Citations (Scopus)

Abstract

Prostate-specific antigen (PSA) is well known as a specific tumor marker for prostate cancer, but carcinoembryonic antigen (CEA)- and carbohydrate antigen 19-9 (CA19-9)-elevating adenocarcinomas originating in the prostate gland are rare. We report a case of metastatic adenocarcinoma of the prostate gland with a high serum level of CEA and CA19-9 in a 78-year-old man in whom prostate cancer (T3N1M1) had been diagnosed 2 years ago and who was treated with androgen deprivation therapy. He visited the emergency department because of a loss of appetite and abdominal pain. The serum CEA and CA19-9 levels were increased to 218.9. ng/mL (normal,

Original language	English
Pages (from-to)	28-30
Number of pages	3
Journal	Urological Science
Volume	25
Issue number	1
DOIs	https://doi.org/10.1016/j.urols.2013.05.005
Publication status	Published - Mar 2014

Keywords

Carbohydrate antigen 19-9 (CA19-9)
Carcinoembryonic antigen (CEA)
Metastatic prostate cancer
Tumor marker

ASJC Scopus subject areas

Urology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.urols.2013.05.005

Cite this

@article{d4380aaa596346ce9dbbdf0f72f4a80a,

title = "Metastatic prostate cancer with elevated serum levels of CEA and CA19-9",

abstract = "Prostate-specific antigen (PSA) is well known as a specific tumor marker for prostate cancer, but carcinoembryonic antigen (CEA)- and carbohydrate antigen 19-9 (CA19-9)-elevating adenocarcinomas originating in the prostate gland are rare. We report a case of metastatic adenocarcinoma of the prostate gland with a high serum level of CEA and CA19-9 in a 78-year-old man in whom prostate cancer (T3N1M1) had been diagnosed 2 years ago and who was treated with androgen deprivation therapy. He visited the emergency department because of a loss of appetite and abdominal pain. The serum CEA and CA19-9 levels were increased to 218.9. ng/mL (normal, ",

keywords = "Carbohydrate antigen 19-9 (CA19-9), Carcinoembryonic antigen (CEA), Metastatic prostate cancer, Tumor marker",

author = "Juang, {Guang Dar} and Yi-Sheng Huang and Wang, {Yuan Hung}",

year = "2014",

month = mar,

doi = "10.1016/j.urols.2013.05.005",

language = "English",

volume = "25",

pages = "28--30",

journal = "Urological Science",

issn = "1879-5226",

publisher = "Elsevier",

number = "1",

}

TY - JOUR

T1 - Metastatic prostate cancer with elevated serum levels of CEA and CA19-9

AU - Juang, Guang Dar

AU - Huang, Yi-Sheng

AU - Wang, Yuan Hung

PY - 2014/3

Y1 - 2014/3

N2 - Prostate-specific antigen (PSA) is well known as a specific tumor marker for prostate cancer, but carcinoembryonic antigen (CEA)- and carbohydrate antigen 19-9 (CA19-9)-elevating adenocarcinomas originating in the prostate gland are rare. We report a case of metastatic adenocarcinoma of the prostate gland with a high serum level of CEA and CA19-9 in a 78-year-old man in whom prostate cancer (T3N1M1) had been diagnosed 2 years ago and who was treated with androgen deprivation therapy. He visited the emergency department because of a loss of appetite and abdominal pain. The serum CEA and CA19-9 levels were increased to 218.9. ng/mL (normal,

AB - Prostate-specific antigen (PSA) is well known as a specific tumor marker for prostate cancer, but carcinoembryonic antigen (CEA)- and carbohydrate antigen 19-9 (CA19-9)-elevating adenocarcinomas originating in the prostate gland are rare. We report a case of metastatic adenocarcinoma of the prostate gland with a high serum level of CEA and CA19-9 in a 78-year-old man in whom prostate cancer (T3N1M1) had been diagnosed 2 years ago and who was treated with androgen deprivation therapy. He visited the emergency department because of a loss of appetite and abdominal pain. The serum CEA and CA19-9 levels were increased to 218.9. ng/mL (normal,

KW - Carbohydrate antigen 19-9 (CA19-9)

KW - Carcinoembryonic antigen (CEA)

KW - Metastatic prostate cancer

KW - Tumor marker

UR - http://www.scopus.com/inward/record.url?scp=84896547234&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896547234&partnerID=8YFLogxK

U2 - 10.1016/j.urols.2013.05.005

DO - 10.1016/j.urols.2013.05.005

M3 - Article

AN - SCOPUS:84896547234

SN - 1879-5226

VL - 25

SP - 28

EP - 30

JO - Urological Science

JF - Urological Science

IS - 1

ER -

Metastatic prostate cancer with elevated serum levels of CEA and CA19-9

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this